Filing Flows › Steris (STE) › R&D spending
Steris (STE) R&D spending by quarter
Steris' R&D spending was $31.5M in Q2 FY27 (second quarter fiscal 2027), +10% from Q1 FY27. Over the last 7 quarters it ranged from $26.4M (Q1 FY26) to $31.5M (Q2 FY27).
| Quarter | R&D spending | Q/Q | Y/Y |
|---|---|---|---|
| Q2 FY27 | $31.5M | +10% | +12% |
| Q1 FY27 | $28.6M | -0.7% | +8% |
| Q4 FY26 | $28.8M | -2% | +4% |
| Q3 FY26 | $29.5M | +5% | — |
| Q2 FY26 | $28.2M | +7% | — |
| Q1 FY26 | $26.4M | -4% | — |
| Q4 FY25 | $27.6M | — | — |
Q2 FY27 at a glance
Steris, Q2 FY27: revenue $1.6B (+9% year over year), operating margin 18.5%, net earnings $214M, operating cash flow $289M. The chart follows the revenue to costs, profit and cash.
Questions
What is Steris' R&D spending?
Steris' R&D spending was $31.5M in Q2 FY27 (second quarter fiscal 2027), +10% from Q1 FY27.
How has Steris' R&D spending changed?
Over the last 7 quarters it ranged from $26.4M (Q1 FY26) to $31.5M (Q2 FY27).